Pang Z - Search Results

1

Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.

Zhong S, Yin H, Liao Y, Yao F, Li Q, Zhang J, Jiao H, Zhao Y, Xu D, Liu S, Song H, Gao Y, Liu J, Ma L, Pang Z, Yang R, Ding C, Sun B, Lin X, Ye X, Guo W, Han B, Zhou BP, Chin YE, Deng J. Zhong S, et al. Among authors: pang z. Cancer Res. 2015 May 1;75(9):1801-14. doi: 10.1158/0008-5472.CAN-14-2005. Epub 2015 Mar 5. Cancer Res. 2015. PMID: 25744720

2

DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.

Fu RJ, He W, Wang XB, Li L, Zhao HB, Liu XY, Pang Z, Chen GQ, Huang L, Zhao KW. Fu RJ, et al. Among authors: pang z. Cell Death Dis. 2017 Jul 27;8(7):e2952. doi: 10.1038/cddis.2017.323. Cell Death Dis. 2017. PMID: 28749461 Free PMC article.

3

MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.

Jin W, Liao X, Lv Y, Pang Z, Wang Y, Li Q, Liao Y, Ye Q, Chen G, Zhao K, Huang L. Jin W, et al. Among authors: pang z. Cell Death Dis. 2017 Aug 10;8(8):e2980. doi: 10.1038/cddis.2017.378. Cell Death Dis. 2017. PMID: 28796259 Free PMC article.

4

MUC1 triggers lineage plasticity of Her2 positive mammary tumors.

Pang Z, Dong X, Deng H, Wang C, Liao X, Liao C, Liao Y, Tian W, Cheng J, Chen G, Yi H, Huang L. Pang Z, et al. Oncogene. 2022 May;41(22):3064-3078. doi: 10.1038/s41388-022-02320-y. Epub 2022 Apr 23. Oncogene. 2022. PMID: 35461328

5

Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer.

Lv Y, Cang W, Li Q, Liao X, Zhan M, Deng H, Li S, Jin W, Pang Z, Qiu X, Zhao K, Chen G, Qiu L, Huang L. Lv Y, et al. Among authors: pang z. Oncogenesis. 2019 Nov 26;8(12):70. doi: 10.1038/s41389-019-0179-2. Oncogenesis. 2019. PMID: 31772161 Free PMC article.

6

WWP1 targeting MUC1 for ubiquitin-mediated lysosomal degradation to suppress carcinogenesis.

Liao C, Yu L, Pang Z, Deng H, Liao X, Li S, Cheng J, Qi M, Chen G, Huang L. Liao C, et al. Among authors: pang z. Signal Transduct Target Ther. 2021 Aug 18;6(1):297. doi: 10.1038/s41392-021-00660-x. Signal Transduct Target Ther. 2021. PMID: 34404764 Free PMC article. No abstract available.

7

MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer.

Li Y, Pang Z, Dong X, Liao X, Deng H, Liao C, Liao Y, Chen G, Huang L. Li Y, et al. Among authors: pang z. Oncotarget. 2017 Dec 15;9(3):3446-3458. doi: 10.18632/oncotarget.23316. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423058 Free PMC article.

8

[Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial].

Tian LY, Lu LG, Tang CW, Xie Y, Luo HS, Tan SY, Pang Z, Zhang YL, Gong LB, Li YM, Chen SH, Shi JP. Tian LY, et al. Among authors: pang z. Zhonghua Gan Zang Bing Za Zhi. 2013 Jul;21(7):528-32. doi: 10.3760/cma.j.issn.1007-3418.2013.07.013. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24074713 Clinical Trial. Chinese.

9

A novel homozygous variant in NLRP5 is associate with human early embryonic arrest in a consanguineous Chinese family.

Xu Y, Qian Y, Liu Y, Wang Q, Wang R, Zhou Y, Zhang C, Pang Z, Ye H, Xue S, Sun L. Xu Y, et al. Among authors: pang z. Clin Genet. 2020 Jul;98(1):69-73. doi: 10.1111/cge.13744. Epub 2020 Apr 16. Clin Genet. 2020. PMID: 32222962

10

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges.

Pang Z, Lu MM, Zhang Y, Gao Y, Bai JJ, Gu JY, Xie L, Wu WZ. Pang Z, et al. Biomark Res. 2023 Dec 1;11(1):104. doi: 10.1186/s40364-023-00534-0. Biomark Res. 2023. PMID: 38037114 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,786 results

Search Page

Filters